STOCK TITAN

Morgan Stanley Smith Barney LLC (NASDAQ: SOPH) files Form 144 for 608 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC filed a Rule 144 notice relating to 608 Restricted Stock Units dated 03/18/2026 to be sold. The entry lists the securities as Common and identifies the issuer role as Issuer.

The filing also shows recent 10b5-1 sales by Philippe Menu, including transactions of 5,000 shares on 03/12/2026 for $22,592.50 and 608 shares on 02/19/2026 for $2,932.38.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the SOPH Form 144 file report?

The filing reports a Rule 144 notice for 608 Restricted Stock Units dated 03/18/2026. It lists the securities as Common and records the issuer role as Issuer, indicating a proposed affiliate sale under Rule 144.

Who appears as the seller in the recent transactions listed?

The excerpt shows multiple 10b5-1 sales by Philippe Menu. Examples include 5,000 shares on 03/12/2026 for $22,592.50 and 608 shares on 02/19/2026 for $2,932.38, indicating prior automated disposition activity.

Are the reported sales open-market or planned trades?

The transactions are labeled as 10b5-1 Sales, which indicates they were effected under pre-arranged trading plans. The filing lists specific trade dates and share amounts for those plan-based sales.

Does the filing state the cash‑flow treatment or proceeds recipient?

The excerpt lists sale amounts per transaction but does not specify the recipient of proceeds or the planned use of funds. The filing identifies the securities as Issuer and records transaction prices for the 10b5-1 sales.
Sophia Genetics Sa

NASDAQ:SOPH

View SOPH Stock Overview

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

351.89M
67.30M
Health Information Services
Healthcare
Link
Switzerland
Rolle